Optimizing midlife metabolic syndrome thresholds for dementia: a prospective study of two UK population-based cohorts
MetS in midlife is potentially an important target for dementia prevention. However, the thresholds for triglycerides and glucose that carry risk need to be tailored specifically for dementia.
Authors
- Benjamin Landré (ORCID: https://orcid.org/0000-0002-3893-4197)
- Marcos D. Machado‐Fragua (ORCID: https://orcid.org/0000-0003-2646-1510)
- Archana Singh‐Manoux (ORCID: https://orcid.org/0000-0002-1244-5037)
- Sèverine Sabia (ORCID: https://orcid.org/0000-0003-3109-9720)
- Aurore Fayossé (ORCID: https://orcid.org/0000-0003-2646-9408)
- Sam Vidil
Institutions
- Inserm (FR)
- Queen Mary University of London (GB)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- University College London (GB)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1186/s13195-025-01732-8
- Citations
- 2
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Wellcome Trust
- Agence Nationale de la Recherche
- National Institutes of Health
- Medical Research Council
- National Institute on Aging